Akron, Synairgen partner on IFN-beta treatment for COVID-19

By The Science Advisory Board staff writers

October 19, 2020 -- Cell therapeutics company Akron Biotechnology and respirator drug development firm Synairgen have partnered to advance interferon-beta (IFN-beta) treatment for patients with COVID-19.

The partnership will leverage SNG001, Synairgen's inhaled IFN-beta COVID-19 candidate. Synairgen reported positive results and safety, biomarker, and efficacy data from a phase II trial of the candidate in 101 patients hospitalized with COVID-19 this summer.

As part of the partnership, Akron Biotech will provide current good manufacturing practices (cGMP)-compliant solutions to aid in developing and commercializing Synairgen's candidate. The partnership leverages Akron's recombinant protein manufacturing expertise and large-scale production capacity to rapidly scale SNG001 production, the companies noted.

Financial terms of the deal were not disclosed.

Validating drug repurposing workflows may help identify new COVID-19 treatments
A research team has strengthened COVID-19 drug repurposing workflows through independent in vitro validation followed by clinical pharmacology data assessments,...
NIH initiates ACTIV trial for COVID-19 immune modulators
The U.S. National Institutes of Health (NIH) has launched an adaptive phase III trial called Accelerating COVID-19 Therapeutic Interventions and Vaccines...
SARS-CoV-2 Nsp1 protein effectively blocks host antiviral defenses
A SARS-CoV-2 protein, Nsp1, may play a critical role in weakening antiviral innate immune defenses, according to a study published in Science...
Pangolin genome offers insight into SARS-CoV-2's jump to humans
Research into the source of SARS-CoV-2 in China has focused on pangolins, anteater-like mammals that may have harbored the virus before it jumped to humans....
Researchers bait viruses with chemically designed structures
A new therapeutic approach for suppressing seasonal influenza that involves synthetic phage shells that interfere with pathogen adhesion is immediately...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter